title: Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.
abstract: To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPCTs). Immunophenotypic aberrant PCs were flow sorted from 20 MGUS, 58 MM, and 13 ExPCT patients. One RAS mutation was identified in 20 MGUS tumors (5%), in contrast to a much higher prevalence of RAS mutations in all stages of MM (about 31%). Further, oncogene analyses showed that RAS mutations are not evenly distributed among different molecular subclasses of MM, with the prevalence being increased in MM-expressing cyclin D1 (P = .015) and decreased in MM with t(4;14) (P = .055). We conclude that RAS mutations often provide a genetic marker if not a causal event in the evolution of MGUS to MM. Surprisingly, RAS mutations were absent in bone marrow tumor cells from all patients with ExPCT, a result significantly different from intramedullary MM (P = .001). From 3 of 6 patients with paired intramedullary and extramedullary PCs and identical immunoglobulin heavy chain gene (IgH) sequences, RAS mutations were identified only in extramedullary PCs, suggesting a role for RAS mutations in the transition from intramedullary to extramedullary tumor.
authors.affiliation: Department of Hematology L 54P4, Herlev Hospital, University of Copenhagen, Herlev, Denmark. thra@herlevhosp.kbhamt.dk
authors.forename: Thomas
authors.initials: T
authors.lastname: Rasmussen
authors.forename: Michael
authors.initials: M
authors.lastname: Kuehl
authors.forename: Marianne
authors.initials: M
authors.lastname: Lodahl
authors.forename: Hans E
authors.initials: HE
authors.lastname: Johnsen
authors.forename: Inger Marie S
authors.initials: IM
authors.lastname: Dahl
mesh_terms: D001483:Base Sequence; D019002:CD56 Antigen / Q000378:metabolism; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology; D019938:Cyclin D1 / Q000378:metabolism; D006801:Humans; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D009101:Multiple Myeloma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D009154:Mutation / Q000235:genetics*; D018631:ras Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*
chemical_list: D019002:CD56 Antigen; D019938:Cyclin D1; D018631:ras Proteins